I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 7 studies | 22% ± 5% | |
| pericyte | 7 studies | 21% ± 4% | |
| type I pneumocyte | 6 studies | 22% ± 6% | |
| endothelial cell | 6 studies | 25% ± 4% | |
| CD8-positive, alpha-beta T cell | 6 studies | 19% ± 3% | |
| natural killer cell | 5 studies | 19% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 22% ± 5% | |
| gamma-delta T cell | 5 studies | 24% ± 9% | |
| ionocyte | 4 studies | 35% ± 11% | |
| pro-B cell | 4 studies | 30% ± 10% | |
| regulatory T cell | 4 studies | 20% ± 4% | |
| T cell | 3 studies | 18% ± 1% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| mucosal invariant T cell | 3 studies | 21% ± 3% | |
| myeloid cell | 3 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 37% ± 13% | |
| glutamatergic neuron | 3 studies | 23% ± 4% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 30% ± 15% |
